Our Labs

Explore our facilities in the US, the UK, China, and Australia.

Five state-of-the-art laboratories. Four continents.

North
America
United
Kingdom
Australia
CHINA

Choose a location

United Kingdom

Bioanalytics Fordham

Your experts in:

  • LC-MS
  • Immunoassay
  • Biomarkers
  • Protein and oligonucleotide LC-MS
  • Immunogenicity
  • Flow cytometry

+ Over 25 years of experience in Europe

Learn More

Analytical Sciences Fordham and Sandwich

Your specialist in:

  • GMP and CMC testing
  • Materials Science

+ Over 20 years of experience in Europe

See Fordham Lab

See Sandwich Lab

North America

Bioanalytics Malvern

Your experts in:

  • MetID, animal dosing (nonGLP, rodent)
  • LC-MS
  • Immunoassay
  • Protein and oligonucleotide LC-MS
  • Immunogenicity
  • Biomarkers
  • DMPK
  • PCR

+ Over 15 years of experience in the US

Learn More

Australia

Bioanalytics Brisbane

Your experts in:

  • LC-MS
  • Immunoassay
  • Biomarkers
  • Early phase clinical research/phase I studies

Specialists in Australia

Learn More

China

Bioanalytics Chongqing

Your experts in:

  • LC-MS
  • Immunoassay
  • Biomarkers
  • Protein and oligonucleotide LC-MS
  • Antibody Drug Conjugates
  • mRNA assays

+ Over 20 years of industry experience

Learn More

For the latest news, visit our LinkedIn

Visit LinkedIn

For the latest Events, visit our Events page

Visit Events

Copyright © 2024 Resolian Inc. All rights reserved.

Scroll to Top

Zhiyang Zhao, Ph.D.

Chief Scientific Officer

Linkedin

Zhiyang Zhao, Ph.D., serves as Chief Scientific Officer (CSO) at Resolian. Dr. Zhao has over 30 years of pharmaceutical industry experience with special focus on drug metabolism and bioanalysis of small and large molecules in drug discovery and development. Dr. Zhao has previously held positions at Pfizer, GlaxoSmithKline, and Amgen. Before joining Resolian in 2015, Dr. Zhao served as Site Director of Preclinical Research at Amgen in Cambridge, Massachusetts, for over a decade. 

Currently, Dr. Zhao serves as an Adjunct Professor at the Eshelman School of Pharmacy of the University of North Carolina at Chapel Hill, North Carolina, and as Editor-in-Chief of Drug Metabolism & Bioanalysis Letters, a journal by Bentham Science, which publishes in all areas of drug metabolism and bioanalysis. Dr. Zhao received his Ph.D. degree in Medicinal Chemistry from Virginia Polytechnic and State University (popularly known as Virginia Tech) in Blacksburg, Virginia. 

Patrick Bennett

Chief Executive Officer

Linkedin

Patrick Bennett has over 35 years of experience in pharmaceutical analysis and laboratory management. Now CEO at Resolian, Patrick’s experience includes the roles of Strategic Marketing Director for Pharma with Thermo Fisher Scientific, LabCorp, and Vice President of Strategy and Development with PPD. 

Patrick earned a B.S. degree in Toxicology and a M.S. degree in Pharmacology from the College of Pharmacy and Allied Health at St. John’s University and an M.B.A in International Marketing from the Martin J. Whitman School of Management at Syracuse University.